These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3918177)

  • 1. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 3. Unanticipated vesicoureteral reflux: a possible sequela of long-term thio-tepa instillations to the bladder.
    Mukamel E; Glanz I; Nissenkorn I; Cytron S; Servadio C
    J Urol; 1982 Feb; 127(2):245-6. PubMed ID: 6801270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis.
    Schmidt JD; Jacobo EC; Weinstein SH
    J Urol; 1976 Dec; 116(6):734-6. PubMed ID: 826656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoureteral reflux of mitomycin C.
    Smith AY; Vitale PJ; Lowe BA; Woodside JR
    J Urol; 1987 Nov; 138(5):1231-3. PubMed ID: 3118057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa.
    Wood DP; Streem SB; Levin HS
    J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
    Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiotepa-induced myelosuppression: review of 670 bladder instillations.
    Soloway MS; Ford KS
    J Urol; 1983 Nov; 130(5):889-91. PubMed ID: 6415297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP; Skinner D; Kasimain D; Friedman NB; Kern WH
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature.
    Silberberg JM; Zarrabi MH
    J Urol; 1987 Aug; 138(2):402-3. PubMed ID: 3110436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa.
    Embon OM; Turani H; Gold CH; Sazbon A
    Eur Urol; 1990; 17(2):181-2. PubMed ID: 2107082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transurethral resection of the intravesical ureter during the removal of bladder tumours.
    Rees RW
    Br J Urol; 1969 Feb; 41(1):2-5. PubMed ID: 5774534
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of cystography in thio-tepa toxicity.
    Orlin I
    J Urol; 1972 Aug; 108(2):257-8. PubMed ID: 4625850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.